Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis

被引：0
|
作者：
Younossi, ZM
McCullough, AJ
Barnes, DS
Post, A
Ong, JP
Mullen, KD
Carey, WD
O'Shea, R
Levinthal, G
Gramlich, T
Martin, LM
Bringman, D
Tavill, A
Ferguson, R
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83944-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A781 / A781
页数：1
相关论文
共 50 条
  • [31] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [32] Eicosapentaenoic acid supplementation for chronic hepatitis C patients during combination therapy of pegylated interferon α-2b and ribavirin
    Kawashima, Aiko
    Tsukamoto, Ikuyo
    Koyabu, Tomoko
    Murakami, Yasuko
    Kawakami, Takayo
    Kakibuchi, Naoko
    Takaguchi, Kouichi
    Kita, Keiji
    Okita, Misako
    LIPIDS, 2008, 43 (04) : 325 - 333
  • [33] Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients
    Voigt, Esther
    Schulz, Christian
    Klausen, Gerd
    Goelz, Joerg
    Mauss, Stefan
    Schmutz, Guenther
    Jessen, Heiko
    Weitner, Lutwin
    Mutz, Antonius
    Schranz, Dietmar
    Rockstroh, Juergen K.
    JOURNAL OF INFECTION, 2006, 53 (01) : 36 - 42
  • [34] IMPACT OF THE VIRAL KINETICS OF CHRONIC HEPATITIS C PATIENTS TREATED WITH TELAPREVIR IN COMBINATION WITH PEGYLATED INTERFERON α2b AND RIBAVIRIN
    Ogawa, E.
    Furusyo, N.
    Nakamuta, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S365 - S365
  • [35] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    AIDS, 2004, 18 (01) : 67 - 73
  • [36] Sustained viral response to pegylated interferon α-2b and ribavirin in chronic hepatitis C refractory to prior treatment
    Mathew, A.
    Peiffer, L. P.
    Rhoades, K.
    McGarrity, T.
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (11) : 1956 - 1961
  • [37] Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment
    A. Mathew
    L. P. Peiffer
    K. Rhoades
    T. McGarrity
    Digestive Diseases and Sciences, 2006, 51 : 1956 - 1961
  • [38] Preliminary treatment results of pegylated interferon alpha 2b and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Madariaga, J
    Levi, D
    Nashida, S
    Kato, T
    Schiff, E
    Tzakis, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 160
  • [39] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [40] Treatment of recurrent hepatitis C infection after liver transplantation: Randomized controlled trial of peg interferon alpha 2b and ribavirin vs. peg interferon alpha 2b, ribavirin and amantadine
    Nair, S
    Lipscomb, J
    Malloy, H
    Loss, G
    Cohen, A
    Eason, J
    GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
12345